Mesenchymal Cell News 11.45 November 19, 2019 | |
| |
TOP STORYScientists demonstrated that bone marrow stromal progenitors possessed a distinct metabolic program and were poised to respond to exogenous metabolic cues that regulated their differentiation fate. [Bone Res] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROThe authors demonstrated that multiple administration of extracellular vesicles from adipose-derived MSCs in deoxycorticosterone acetate (DOCA)-salt hypertensive model could protect renal tissue by maintaining its filtration capacity. [Mol Ther Methods Clin Dev] Abstract | Full Article The viability of human bone marrow-derived MSCs postcryopreservation reached 78±3%, which was threefold higher than that obtained by the conventional warming method. The cells postcryopreservation maintained their normal attachment, proliferation, surface marker expression, and intact multilineage differentiation properties. [Acta Biomater] Abstract | Graphical Abstract Arsenic Induces Human Chondrocyte Senescence and Accelerates Rat Articular Cartilage Aging Arsenic trioxide significantly induced senescence in human articular chondrocytes by increasing senescence-associated β-galactosidase activity and protein expression of p16, p53, and p21. [Arch Toxicol] Abstract The authors found that bone marrow-derived stromal cells from both cohorts met the standard criteria for MSC, exhibiting similar morphology, growth kinetics, gene expression profiles, and pro-angiogenic and immunosuppressive potential and the capacity to differentiate toward adipogenic, chondrogenic, and osteogenic lineages. [Front Immunol] Full Article | Graphical Abstract Success Rates in Isolating Mesenchymal Stem Cells from Permanent and Deciduous Teeth The overall successful isolation rate of stem cells from human exfoliated deciduous teeth and human dental pulp stem cells was 82% and 70%. [Sci Rep] Full Article Researchers showed that alginate encapsulation was an effective method of human limbus-derived stromal/MSC preservation offering high cell viability over prolonged durations in transit at room temperature. [Sci Rep] Full Article IN VIVOMSC transplantation normalized transgenic murine model of adipocyte insulin resistance body and epididymal fat weights and was associated with increased leptin levels, a sign of adipocyte maturation. [J Neurochem] Abstract Adipose tissue MSC-conditioned medium administration decreased beta amyloid plaques and enhanced neuronal survival in Alzheimer’s disease brain rats. In addition, TLR2 and TLR4 expression decreased in treatment group. [Behav Brain Res] Abstract Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSScientists discuss the current findings in the field of MSCs derived extracellular vesicle (EV)-based therapies in immune-mediated disorders and approaches to scale EV production for clinical use. [Front Immunol] Full Article Immune Modulation by Mesenchymal Stem Cells MSCs could promote inflammation when the immune system is underactivated and restrain inflammation when the immune system is overactivated to avoid self-overattack. These cells express many immune suppressors to switch them from a pro-inflammatory phenotype to an anti-inflammatory phenotype, resulting in immune effector cell suppression and immune suppressor cell activation. [Cell Prolif] Full Article Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSBrainStorm Cell Therapeutics, Inc. announced that the company has received a $495,330 grant from the National Multiple Sclerosis Society, through its Fast Forward program, to advance BrainStorm’s Phase II open-label, multicenter clinical trial of repeated intrathecal administration of NurOwn® in participants with progressive Multiple Sclerosis. [BrainStorm Cell Therapeutics, Inc.] Press Release Aadi Bioscience, Inc. released its independent radiology reviewed data from the nab-sirolimus registration trial (AMPECT) for Advanced Malignant PEComa- a rare form of sarcoma for which there is no currently approved therapy. [Aadi Bioscience, Inc. (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWSForeign Interference Fears Prompt Guidelines for Australian Universities New guidelines will help Australian universities protect themselves against foreign interference, says the country’s government. The advice follows concerns that foreign groups or governments, such as the government of China, might be seeking to instigate campus activities that are against Australia’s interests. [Nature News] Editorial Violent Clashes at Hong Kong Universities Disrupt Research Three universities in Hong Kong have cancelled classes on campus for the rest of the term after violent clashes between police and protestors erupted in the grounds. At least another four universities have also cancelled classes — in some cases for the rest of the year — over safety concerns. [Nature News] Editorial
| |
EVENTSNEW 10th International Meeting of the Stem Cell Network North Rhine-Westphalia Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Graduate Student Position – Stem Cell Biology (Technion – Israel Institute of Technology) Researcher – Musculoskeletal Disorders (National University of Ireland Galway) Postdoctoral Researcher – Embryonic and Adult Stem Cells (Yale University School of Medicine) Faculty Position – Regenerative Medicine and Tissue Engineering (Columbia University) Research Assistant – Stem Cells and Engineering (New York Blood Center) Researcher – Biomaterials and Stem Cells (National University of Ireland Galway) Postdoctroal Researcher – CRISPR/Cas9 in Tissue Regeneration (Howard Hughes Medical Institute) Tenure-Track Positions – Biologic and Materials Sciences and Prosthodontics (University of Michigan) Professor Positions – Biomedical Science (The Chinese University of Hong Kong) Assistant Professor – Cell and Molecular Biology (Boston University) Postdoctoral Researcher – Stem Cells (University of South Florida) Postdoctoral Researcher – Proteoglycans in Post-Traumatic Osteoarthritis (Drexel University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|